Joseph C. Marini

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis

D. Craig Hooper, Omar Bagasra, Joseph C. Marini et al. · Proceedings of the National Academy of Sciences · 1997 · 333 citations · Full text

Asthma, Allergy Medicine, Nitric Oxide +19

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Honghui Zhou, Haishan Jang, Roy Fleischmann et al. · The Journal of Clinical Pharmacology · 2007 · 191 citations

Inflammation, Rheumatology, Rheumatoid Disorder +15

Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL‐12/23p40, in Patients With Moderate to Severe Plaque Psoriasis

Yaowei Zhu, Chuanpu Hu, Ming Lu et al. · The Journal of Clinical Pharmacology · 2009 · 166 citations

Rheumatoid Disorder, Autoimmune Disease, Medicine +13

New Genetic Loci That Control Susceptibility and Symptoms of Experimental Allergic Encephalomyelitis in Inbred Mice

Russell J. Butterfield, Jayce Sudweeks, Elizabeth P. Blankenhorn et al. · The Journal of Immunology · 1998 · 154 citations · Full text

Genetics, Immunology, Genetic Epidemiology +20

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

Sudha Visvanathan, Carrie Wagner, Joseph C. Marini et al. · Annals of the Rheumatic Diseases · 2007 · 150 citations · Full text